These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 23563012)

  • 1. Emergence of a highly resistant Clostridium difficile strain (NAP/BI/027) in a tertiary care center in Saudi Arabia.
    Alzahrani N; Johani SA
    Ann Saudi Med; 2013; 33(2):198-9. PubMed ID: 23563012
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuing diarrhoea after ten days of oral metronidazole or oral vancomycin for presumed, hospital-acquired Clostridium difficile colitis in elderly hospital patients.
    Parks T; Wallis S; Wilson J; Gkrania-Klotsas E; Nicholl C
    J Hosp Infect; 2010 Apr; 74(4):403-5. PubMed ID: 20153080
    [No Abstract]   [Full Text] [Related]  

  • 3. Two case reports of Clostridium difficile bacteremia, one with the epidemic NAP-1 strain.
    Hemminger J; Balada-Llasat JM; Raczkowski M; Buckosh M; Pancholi P
    Infection; 2011 Aug; 39(4):371-3. PubMed ID: 21509425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic approach to Clostridium difficile infection.
    Vaishnavi C
    Indian J Gastroenterol; 2010 Jul; 29(4):137-9. PubMed ID: 20717859
    [No Abstract]   [Full Text] [Related]  

  • 5. Clostridium difficile infection.
    Clark T; Wiselka M
    Clin Med (Lond); 2008 Oct; 8(5):544-7. PubMed ID: 18975492
    [No Abstract]   [Full Text] [Related]  

  • 6. Decreased cure and increased recurrence rates for Clostridium difficile infection caused by the epidemic C. difficile BI strain.
    Petrella LA; Sambol SP; Cheknis A; Nagaro K; Kean Y; Sears PS; Babakhani F; Johnson S; Gerding DN
    Clin Infect Dis; 2012 Aug; 55(3):351-7. PubMed ID: 22523271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the vulnerable period for re-establishment of Clostridium difficile colonization after treatment of C. difficile infection with oral vancomycin or metronidazole.
    Abujamel T; Cadnum JL; Jury LA; Sunkesula VC; Kundrapu S; Jump RL; Stintzi AC; Donskey CJ
    PLoS One; 2013; 8(10):e76269. PubMed ID: 24098459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical manifestations, treatment and control of infections caused by Clostridium difficile.
    Bouza E; Muñoz P; Alonso R
    Clin Microbiol Infect; 2005 Jul; 11 Suppl 4():57-64. PubMed ID: 15997485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.
    Alzouby S; Baig K; Alrabiah F; Shibl A; Al-Nakhli D; Senok AC
    J Infect Public Health; 2020 Jul; 13(7):1012-1017. PubMed ID: 31831398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repurposing a platelet aggregation inhibitor ticagrelor as an antimicrobial against Clostridioides difficile.
    Phanchana M; Phetruen T; Harnvoravongchai P; Raksat P; Ounjai P; Chankhamhaengdecha S; Janvilisri T
    Sci Rep; 2020 Apr; 10(1):6497. PubMed ID: 32300130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridioides difficile from intracardiac vegetation.
    Chaudhry R; Khullar S; Arif N; Sagar T; Meena D; Kumar Chowdhury U
    Anaerobe; 2021 Jun; 69():102350. PubMed ID: 33610766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and emerging therapies in treatment of Clostridium difficile infection.
    Goyal H; Perisetti A; Rehman MR; Singla U
    Eur J Gastroenterol Hepatol; 2018 Jun; 30(6):589-597. PubMed ID: 29521664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.
    Rao K; Malani PN
    JAMA; 2020 Apr; 323(14):1403-1404. PubMed ID: 32150234
    [No Abstract]   [Full Text] [Related]  

  • 14. Antimicrobial resistance in Clostridioides difficile.
    O'Grady K; Knight DR; Riley TV
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2459-2478. PubMed ID: 34427801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
    Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
    Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea.
    Tart SB
    J Pharm Pract; 2013 Oct; 26(5):488-90. PubMed ID: 23940121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous metronidazole for fulminant Clostridioides difficile infection.
    Pipitone G; Granata G; Sartelli M; Gizzi A; Imburgia C; Cascio A; Iaria C
    Clin Microbiol Infect; 2023 May; 29(5):656-657. PubMed ID: 36739974
    [No Abstract]   [Full Text] [Related]  

  • 18.
    Vidović K; Bogdanić N; Balen Topić M
    Infect Dis (Lond); 2019 Jul; 51(7):554-557. PubMed ID: 31081416
    [No Abstract]   [Full Text] [Related]  

  • 19. Multihospital outbreak of Clostridium difficile infection, Cleveland, Ohio, USA.
    Jump RL; Riggs MM; Sethi AK; Pultz MJ; Ellis-Reid T; Riebel W; Gerding DN; Salata RA; Donskey CJ
    Emerg Infect Dis; 2010 May; 16(5):827-9. PubMed ID: 20409374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridioides (Clostridium) difficile-associated disease: Epidemiology among patients in a general hospital in Saudi Arabia.
    Al-Tawfiq JA; Rabaan AA; Bazzi AM; Raza S; Noureen M
    Am J Infect Control; 2020 Oct; 48(10):1152-1157. PubMed ID: 32122671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.